JNJ-39393406 has been used in trials studying the treatment and basic science of DEPRESSION, Schizophrenia, Smoking Cessation, Cognition Disorders, and Alzheimer's Disease.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.